Remove 2023 Remove Labelling Remove Packaging
article thumbnail

Labelling of Dispensed Medicine

RX Note

Labelling Requirements A ll dispensed medicine should be labelled according to the requirement stated by the law. NOTE: It is advisable for labels to be printed. Consequently, a patient-centred label strategy is introduced to promote appropriate medication use and adherence. Suggestions include Use larger font sizes (e.g.

article thumbnail

Europe’s pharmaceutical packaging market to value over $35bn by 2028

European Pharmaceutical Review

Europe’s pharmaceutical packaging and labelling market is projected to reach $35.78 billion in 2022, the pharmaceutical packaging and labelling market in Europe is expected to expand at a compound annual growth rate (CAGR) of 4.78 percent between the forecast period: 2023 and 2028. Having been valued at $27.04

Packaging 118
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Guidance for medicine packaging under Windsor Framework

European Pharmaceutical Review

The Windsor Framework, announced on 9 June 2023 by the Medicines and Healthcare products Regulatory Agency (MHRA), provides a long-term solution for the supply of medicines into Northern Ireland. The agreement stipulates that certain conditions must be met in the labelling and packaging of these medicinal products.

Packaging 105
article thumbnail

Ampoules packaging market forecast to 2033

European Pharmaceutical Review

A report by The Brainy Insights has predicted that the ampoules packaging market will value $9.83 This is expected to be largely driven by increasing demand for this packaging type. Considering material type, glass ampoule packaging was found to hold a market share of around 77 percent in 2023, in comparison to plastic.

article thumbnail

Electronic smart packaging market to value nearly $3b in 2033

European Pharmaceutical Review

A market report has identified that global demand for electronic smart packaging will reach $2.6 percent from 2023, according to the data. Smart packaging has potential for the integration of electronic functionality, enabling compliance, material identification, condition monitoring and asset tracking of pharmaceutical products.

article thumbnail

September 2023 Newsletter

Safe Biologics

6 would prevent the HHS Secretary from requiring a switching study as part of the data package to receive the interchangeable designation. Register for the 2023 National Policy & Advocacy Summit on Biologics here. However, S.6 ASBM surveys of U.S. Read the new FDA’ Guidance here. Submit comments on the guidance here.

article thumbnail

November 2023 Newsletter

Safe Biologics

The guidance removed the interchangeability statement from the product label/package insert of interchangeable biosimilars. ASBM Exhibits at ACR Convergence 2023 From November 12-14, ASBM exhibited at Booth #2612 at ACR Convergence 2023 in San Diego, CA. Learn more about ACR Convergence 2023 here.